<SEC-DOCUMENT>0001493152-25-009894.txt : 20250311
<SEC-HEADER>0001493152-25-009894.hdr.sgml : 20250311
<ACCEPTANCE-DATETIME>20250311172633
ACCESSION NUMBER:		0001493152-25-009894
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250311
DATE AS OF CHANGE:		20250311

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTELLIGENT BIO SOLUTIONS INC.
		CENTRAL INDEX KEY:			0001725430
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				821512711
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-264218
		FILM NUMBER:		25728887

	BUSINESS ADDRESS:	
		STREET 1:		135 W 41ST ST,
		STREET 2:		FLOOR 5
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		646-233-6971

	MAIL ADDRESS:	
		STREET 1:		135 W 41ST ST,
		STREET 2:		FLOOR 5
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GBS Inc.
		DATE OF NAME CHANGE:	20190919

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Glucose Biosensor Systems (Greater China) Holdings, Inc.
		DATE OF NAME CHANGE:	20171214
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>form424b5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
Pursuant to Rule 424(b)(5)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
No. 333-264218</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS
SUPPLEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(To
Prospectus Supplement dated September 18, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and
Prospectus dated April 20, 2022)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="form424b5_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Intelligent
Bio Solutions, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to $1,376,530 of Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Prospectus Supplement dated March 11, 2025, or this supplement, supplements, modifies and supersedes, only to the extent indicated herein,
certain information contained in our prospectus supplement dated September 18, 2024, (together with the accompanying prospectus, the
&ldquo;Initial Prospectus Supplement&rdquo;), relating to the offer and sale, from time to time, of shares of our Common Stock to or
through Ladenburg Thalmann &amp; Co. Inc. (&ldquo;Ladenburg&rdquo;), acting as our sales agent or principal, in accordance with the terms
of that certain At The Market Offering Agreement, dated September 18, 2024 (&ldquo;ATM Agreement&rdquo;), we entered into with Ladenburg.
This supplement should be read in conjunction with, is not complete without, and may not be delivered or utilized except in connection
with, the Initial Prospectus Supplement, including all supplements thereto and documents incorporated by reference therein. If there
is any inconsistency between the information in the Initial Prospectus Supplement and this supplement, you should rely on the information
in this supplement. Any information that is modified or superseded in the Initial Prospectus Supplement shall not be deemed to constitute
a part of the Initial Prospectus Supplement, except as modified or superseded by this supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ATM Agreement with Ladenburg provides that we may issue and sell through or to Ladenburg, as sales agent and/or principal, from time
to time during the term of the ATM Agreement and on the terms set forth therein, up to the lesser of such number of shares (the &ldquo;Shares&rdquo;)
of the Company&rsquo;s common stock, $0.01 par value per share (&ldquo;Common Stock&rdquo;), that does not exceed (a) the number or dollar
amount of shares of Common Stock registered on the our universal shelf registration statement on Form S-3 (registration no. 333-264218),
pursuant to which the offering is being made, (b) the number of authorized but unissued shares of Common Stock (less the number of shares
of Common Stock issuable upon exercise, conversion or exchange of any outstanding securities of the Company or otherwise reserved from
the Company&rsquo;s authorized capital stock), or (c) the number or dollar amount of shares of Common Stock that would cause the Company
or the offering of the Shares to not satisfy the eligibility and transaction requirements for use of Form S-3, including, if applicable,
General Instruction I.B.6 of Form S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 11, 2025, the aggregate market value of our outstanding common stock held by non-affiliates, or our public float, was approximately
$17,658,960, which amount is based on 6,689,000 outstanding shares of Common Stock held by non-affiliates and a per share price of $2.64
on February 19, 2025, which was the highest closing sale price of our Common Stock on the Nasdaq Capital Market within 60 days of the
filing date of this supplement. Accordingly, under the terms of the ATM Agreement, we may offer and sell through the Initial Prospectus
Supplement, as amended and supplemented by this supplement, shares of common stock having an aggregate offering price of up to $5,886,320,
from time to time to or through Ladenburg, acting as our sales agent or principal, subject to compliance requirements to use of Form
S-3, including General Instruction I.B.6 of Form S-3. We have sold $4,509,789.61 of securities pursuant to General Instruction I.B.6.
of Form S-3 during the 12-calendar month period ending on and including the date of this supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are filing this supplement to update and amend the Initial Prospectus Supplement to increase the maximum amount of shares that we are
eligible to sell pursuant to the ATM Agreement under General Instruction I.B.6. As a result of these limitations, as of the date of this
supplement, shares of Common Stock having an aggregate gross sales price of up to $1,376,530 remain available for offer and sale under
the ATM Agreement through the Initial Prospectus Supplement, as amended and supplemented by this supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our public float subsequently increased such that we could sell additional amounts of our Common Stock pursuant to General Instruction
I.B.6. of Form S-3, we will file another supplement to the Initial Prospectus Supplement prior to making any sales of Common Stock under
the ATM Agreement in excess of the amount of Common Stock covered by the Initial Prospectus Supplement, as amended by this supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shares of Common Stock are listed on The Nasdaq Capital Market under the symbol &ldquo;INBS&rdquo;. The last sale price of our shares
of Common Stock on March 10, 2025, was $2.22 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page S-4 of the Initial Prospectus Supplement
and the risk factors incorporated by reference into the Initial Prospectus Supplement, which is incorporated by reference herein, to
read about the risks you should consider before purchasing our securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed
upon the adequacy or accuracy of this or the Initial Prospectus Supplement or the accompanying prospectus. Any representation to the
contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Ladenburg
Thalmann</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus supplement is March 11, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>form424b5_001.jpg
<TEXT>
begin 644 form424b5_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !0 3X# 2(  A$! Q$!_\0
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M+_T,OC3_ ,#;3_Y%K[F6ES1_KCQ#_P!!M3[V+ZM1_D/AC_AT/\)?^AE\:?\
M@;:?_(M'_#H?X2_]#+XT_P# VT_^1:^YZ*K_ %RX@_Z#:G_@3#ZM1_D/AC_A
MT/\ "7_H9O&G_@;:?_(M'_#H?X2_]#-XT_\  VT_^1:^YZ*7^N7$'_0;4_\
M F'U:C_(?#'_  Z'^$O_ $,OC3_P-M/_ )%H_P"'0_PE_P"AE\:?^!MI_P#(
MM?<]%/\ UQX@_P"@VI_X$P^K4?Y#X8_X=#_"7_H9?&G_ (&VG_R+1_PZ'^$O
M_0R^-/\ P-M/_D6ON>C-'^N7$'_0;4_\"8?5J/\ (?#'_#H?X2_]#+XT_P#
MVT_^1:/^'0_PE_Z&7QI_X&VG_P BU]ST4?ZY<0?]!M3_ ,"8?5J/\A\,?\.A
M_A+_ -#+XT_\#;3_ .1:/^'0_P )?^AE\:?^!MI_\BU]ST9H_P!<N(/^@VI_
MX$P^K4?Y#X8_X=#_  E_Z&7QI_X&VG_R+1_PZ'^$O_0R^-/_  -M/_D6ON?-
M&:/]<N(/^@VI_P"!,/JU'^0^&/\ AT/\)?\ H9?&G_@;:?\ R+1_PZ'^$O\
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M^?O_ /'TK$T>UU#Q%XYA\0WVGOHT-AITUG;VEQ*CS-Y\D+R.^QW39_HR;/\
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M_P"3E-!_[%:V_P#2N[K]=K7B)4_N\5^1/_!7#_DY30?^Q6MO_2N[K]5\+_\
MDIZ'I+\F<N,_AGTK_P $A_\ DW?Q/CK_ ,)5/_Z1VE?<_7Z5^1?[#_[<7@O]
MF/X7ZMX;\3:1X@U&_N]8EU)7TFVMWBV-#"@!+S)\W[EJ^C3_ ,%=_A+_ -"S
MXUS_ ->5I_\ )-3Q5PKG>+SO%UZ&$G*,IMII:6%1K4H4H+F/N5D#4;*^&_\
MA[Q\)?\ H6?&G_@%:?\ R51_P]X^$O\ T+/C3_P"M/\ Y*KYC_4[B#_H"J?^
M LU^L4?YS[C\E?2D\K_::OAW_A[Q\)?^A9\:?^ 5I_\ )5'_  ]X^$O_ $+/
MC3_P"M/_ )*H_P!3N(/^@*I_X"P^L4?YS[EVCTILD*2?>%?#G_#WCX2_]"UX
MT_\  *T_^2J/^'O'PE_Z%KQI_P" 5I_\E4?ZG<0?] 53_P !8OK-'^<^X?LZ
M?[5.\E?2OAS_ (>\?"7_ *%KQI_X!6G_ ,E4?\/>/A+_ -"UXT_\ K3_ .2J
M7^IO$'_0%4_\!8_K-+^<^Y3&K=14:0J@^7A/[M?#W_#WGX2_]"UXT_\  *T_
M^2J/^'O/PE_Z%KQI_P" 5I_\E4_]3N(/^@*I_P" L/K-+^<^X_*7L-M/5=O2
MOAG_ (>\?"7_ *%KQI_X!6G_ ,E4?\/>/A+_ -"UXT_\ K3_ .2J7^IO$'_0
M%4_\!8OK-'^<^Y-E,^SK_M5\/?\ #WGX2_\ 0M>-?_ *T_\ DJC_ (>\_"7_
M *%KQK_X!6G_ ,E4?ZG<0?\ 0%4_\!8_K-+^<^Y%CV_Q,?QI/(7TKX<_X>\?
M"7_H6O&G_@%:?_)5'_#WCX2_]"UXT_\  *T_^2J/]3N(/^@*I_X"Q?6:/\Y]
MQ/;J_7=0ENJ=-W_?1KX=_P"'O/PF_P"A9\:?^ -I_P#)-'_#WGX3?]"SXT_\
M ;3_ .2:/]3.(/\ H"J?<ROK-/\ G/N8+MICPK)UKX<_X>\?"7_H6O&G_@%:
M?_)5'_#WCX2_]"UXT_\  *T_^2J/]3>(/^@*I]S)^LT?YS[C2%8^E#PK)UKX
M<_X>\_"7_H6O&G_@%:?_ "51_P />?A+_P!"UXT_\ K3_P"2J/\ 4[B#_H"J
M?^ L?UFE_.?<7D)\_P#M=:7R5]*^'/\ A[S\)?\ H6O&G_@%:?\ R51_P]Y^
M$O\ T+7C3_P"M/\ Y*I_ZG<0?] 53_P%A]9I?SGW'Y"^E$D*2?>%?#G_  ]X
M^$O_ $+7C3_P"M/_ )*H_P"'O'PE_P"A:\:?^ 5I_P#)5'^IW$'_ $!5/_ 6
M+ZS1_G/N);=1_$WYT-%_MM7P[_P]X^$O_0M>-/\ P"M/_DJC_A[Q\)?^A:\:
M?^ 5I_\ )5'^IW$'_0%4_P# 6'UFC_.?<JH%Z"E9=U?#/_#WCX2_]"UXT_\
M *T_^2J/^'O'PE_Z%KQI_P" 5I_\E4?ZG<0?] 53_P !8?6:/\Y]Q26Z2=14
M?V.+L-G^Y7Q#_P />?A+_P!"UXT_\ K3_P"2J/\ A[S\)?\ H6O&G_@%:?\
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H--(2-LC_ "XF7O7Z3X><-YO@<_I5\5AIP@E+5JRV.3%5J4Z?NR/_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
